000			02265 a2200649 4500
005			20250515005018.0
264		0	_c20051205
008			200512s 0 0 eng d
022			_a1610-0379
024	7		_a10.1046/j.1439-0353.2003.03711.x _2doi
040			_aNLM _beng _cNLM
100	1		_aBohmeyer, J
245	0	0	_aBexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. _h[electronic resource]
260			_bJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG _cOct 2003
300			_a785-9 p. _bdigital
500			_aPublication Type: Comparative Study; Evaluation Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAminoquinolines _xtherapeutic use
650	0	4	_aAnticarcinogenic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols
650	0	4	_aBexarotene
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide
650	0	4	_aDisease Progression
650	0	4	_aDoxorubicin
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImiquimod
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInterferons _xtherapeutic use
650	0	4	_aLymphoma, T-Cell, Cutaneous _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPUVA Therapy
650	0	4	_aPilot Projects
650	0	4	_aPrednisone
650	0	4	_aRemission Induction
650	0	4	_aSkin _xpathology
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aTacrolimus _xtherapeutic use
650	0	4	_aTetrahydronaphthalenes _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine
700	1		_aStadler, R
700	1		_aKremer, A
700	1		_aNashan, D
700	1		_aMuche, M
700	1		_aGellrich, S
700	1		_aLuger, T
700	1		_aSterry, W
773	0		_tJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG _gvol. 1 _gno. 10 _gp. 785-9
856	4	0	_uhttps://doi.org/10.1046/j.1439-0353.2003.03711.x _zAvailable from publisher's website
999			_c15906456 _d15906456